Efficacy, Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy: a Randomized, Double-blind, Placebo Controlled, Crossover Trial
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Lacosamide (Primary)
- Indications Peripheral neuropathies
- Focus Therapeutic Use
- Acronyms MaYa-Nav1.7
- 21 Sep 2017 According to European clinical trials database the trial has been completed
- 26 Aug 2016 Planned End Date changed from 1 Oct 2016 to 1 Mar 2017.
- 26 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Feb 2017.